Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5226
iBio
IBIO
$47.5M
| $2 | ﹤0.01% |
2
-3,253
| -100% | -$4.48K |
2026 Q2
1 quarter
|
|
5227
Intrusion
INTZ
$15.9M
| $2 | ﹤0.01% |
3
-118
| -98% | -$92 |
2026 Q2
1 quarter
|
|
5228
iSpecimen
ISPC
$2.05M
| $2 | ﹤0.01% |
+2
| New | +$4 |
2026 Q3
0 quarters
|
|
5229
Jet.AI
JTAI
$3.25M
| $2 | ﹤0.01% |
1
-283
| -100% | -$665 |
2026 Q2
1 quarter
|
|
5230
Local Bounti
LOCL
$20.3M
| $2 | ﹤0.01% |
+2
| New | +$2 |
2026 Q3
0 quarters
|
|
5231
Modular Medical
MODD
$12.6M
| $2 | ﹤0.01% |
1
-352
| -100% | -$1.02K |
2026 Q2
1 quarter
|
|
5232
PDS Biotechnology
PDSB
$89.1M
| $2 | ﹤0.01% |
2
-580
| -100% | -$329 |
2026 Q2
1 quarter
|
|
5233
Phio Pharmaceuticals
PHIO
$9.31M
| $2 | ﹤0.01% |
2
-229
| -99% | -$242 |
2026 Q2
1 quarter
|
|
5234
Children's Place
PLCE
$7.16M
| $2 | ﹤0.01% |
1
-11
| -92% | -$28 |
2025 Q3
4 quarters
|
|
5235
PharmaCyte Biotech
PMCB
$3.86M
| $2 | ﹤0.01% |
4
-188
| -98% | -$103 |
2026 Q2
1 quarter
|
|
5236
Rain Enhancement Technologies
RAIN
$5.89M
| $2 | ﹤0.01% |
+2
| New | +$2 |
2026 Q3
0 quarters
|
|
5237
Reborn Coffee
REBN
$10.4M
| $2 | ﹤0.01% |
1
-163
| -99% | -$208 |
2026 Q2
1 quarter
|
|
5238
Rocky Mountain Chocolate Factory
RMCF
$7.97M
| $2 | ﹤0.01% |
+2
| New | +$2 |
2026 Q3
0 quarters
|
|
5239
Rapid Micro Biosystems
RPID
$32.2M
| $2 | ﹤0.01% |
2
-335
| -99% | -$548 |
2025 Q4
3 quarters
|
|
5240
Swvl Holdings Corp Warrant
SWVLW
$112K
| $2 | ﹤0.01% |
238
| – | – |
2022 Q2
17 quarters
|
|
5241
Talphera
TLPH
$54.5M
| $2 | ﹤0.01% |
2
-959
| -100% | -$1.21K |
2026 Q2
1 quarter
|
|
5242
AgEagle Aerial Systems
UAVS
$20M
| $2 | ﹤0.01% |
2
-4,308
| -100% | -$3.9K |
2026 Q2
1 quarter
|
|
5243
Westwater Resources
WWR
$50.2M
| $2 | ﹤0.01% |
3
-2,945
| -100% | -$1.52K |
2026 Q2
1 quarter
|
|
5244
Arq
ARQ
$112M
| $2 | ﹤0.01% |
1
-2,161
| -100% | -$4.62K |
2024 Q2
9 quarters
|
|
5245
GrabAGun Digital Holdings
PEW
$55.5M
| $2 | ﹤0.01% |
1
-66
| -99% | -$161 |
2025 Q3
4 quarters
|
|
5246
VIDA Global Inc
VIDA
$11.2M
| $2 | ﹤0.01% |
+1
| New | +$2 |
2026 Q3
0 quarters
|
|
5247
Atlantic American Corp
AAME
$22.6M
| $1 | ﹤0.01% |
+1
| New | +$1 |
2026 Q3
0 quarters
|
|
5248
reAlpha
AIRE
$2.87M
| $1 | ﹤0.01% |
1
-33
| -97% | -$50 |
2026 Q2
1 quarter
|
|
5249
AquaBounty Technologies
AQB
$5.03M
| $1 | ﹤0.01% |
+1
| New | +$1 |
2026 Q3
0 quarters
|
|
5250
Azitra
AZTR
$4.44M
| $1 | ﹤0.01% |
+1
| New | +$2 |
2026 Q2
1 quarter
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.